Literature DB >> 1372927

Prevalence and geographical distribution of major LDL receptor gene rearrangements in Finland.

K Aalto-Setälä1, U M Koivisto, T A Miettinen, H Gylling, Y A Kesäniemi, M Savolainen, K Pyörälä, T Ebeling, I Mononen, H Turtola.   

Abstract

In order to determine the prevalence of major rearrangements of the low density lipoprotein (LDL) receptor gene in Finland, DNA samples of 199 unrelated Finnish patients with the heterozygous form of familial hypercholesterolaemia (FH) were examined by Southern blot analysis. The FH-Helsinki mutation, characterized by a 9.5-kb deletion in the 3'-end of the LDL receptor gene, was found in 75 (38%) of the patients. The prevalence of this mutation ranged from 26-58% in different areas of Finland. A striking exception was the North Karelia region, where only one out of 26 (4%) FH patients was found to carry the FH-Helsinki allele. Two patients were found to carry other types of large nucleotide rearrangements of the LDL receptor gene. One mutation was a 7.5-kb deletion eliminating exons 7 to 10, and the other was a 13-kb deletion covering exons 11 to 16 of the LDL receptor gene. Serum lipoprotein levels were very similar in each category of mutation, i.e. in patients with the FH-Helsinki gene, those with the two other types of deletion, and the remaining patients with as yet unknown types of LDL receptor gene defects. These results show that, even in genetically uniform populations, FH may be heterogeneous at the DNA level. DNA techniques enable an unequivocal diagnosis for almost 40% of the Finnish patients with the heterozygous form of FH.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372927     DOI: 10.1111/j.1365-2796.1992.tb00528.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  6 in total

1.  Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews.

Authors:  R Durst; R Colombo; S Shpitzen; L B Avi; Y Friedlander; R Wexler; F J Raal; D A Marais; J C Defesche; M Y Mandelshtam; M J Kotze; E Leitersdorf; V Meiner
Journal:  Am J Hum Genet       Date:  2001-04-17       Impact factor: 11.025

2.  The familial hypercholesterolemia (FH)-North Karelia mutation of the low density lipoprotein receptor gene deletes seven nucleotides of exon 6 and is a common cause of FH in Finland.

Authors:  U M Koivisto; H Turtola; K Aalto-Setälä; B Top; R R Frants; P T Kovanen; A C Syvänen; K Kontula
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

3.  A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia.

Authors:  U M Koivisto; J J Palvimo; O A Jänne; K Kontula
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

4.  Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: identification of two common missense mutations (Gly823-->Asp and Leu380-->His) and eight rare mutations of the LDL receptor gene.

Authors:  U M Koivisto; J S Viikari; K Kontula
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

5.  Analysis of sequence variations in low-density lipoprotein receptor gene among Malaysian patients with familial hypercholesterolemia.

Authors:  Alyaa Al-Khateeb; Mohd K Zahri; Mohd S Mohamed; Teguh H Sasongko; Suhairi Ibrahim; Zurkurnai Yusof; Bin A Zilfalil
Journal:  BMC Med Genet       Date:  2011-03-19       Impact factor: 2.103

6.  Genetic screening for homozygous and heterozygous familial hypercholesterolemia.

Authors:  Maria C Izar; Valéria A Machado; Francisco A Fonseca
Journal:  Appl Clin Genet       Date:  2010-12-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.